BR112016025370A2 - composição tópica - Google Patents

composição tópica

Info

Publication number
BR112016025370A2
BR112016025370A2 BR112016025370A BR112016025370A BR112016025370A2 BR 112016025370 A2 BR112016025370 A2 BR 112016025370A2 BR 112016025370 A BR112016025370 A BR 112016025370A BR 112016025370 A BR112016025370 A BR 112016025370A BR 112016025370 A2 BR112016025370 A2 BR 112016025370A2
Authority
BR
Brazil
Prior art keywords
topical composition
extract
mustard seed
scalp
cytotoxic
Prior art date
Application number
BR112016025370A
Other languages
English (en)
Inventor
Jenkins Gail
Elizabeth Pople Jennifer
Ian Fowler Mark
John Berry Mark
Pamela Redfern Sally
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of BR112016025370A2 publication Critical patent/BR112016025370A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01147—Thioglucosidase (3.2.1.147), i.e. myrosinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A61K2800/882—Mixing prior to application

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

os inventores observaram que o extrato aquoso de semente de mostarda parece ser citotóxico para células de fibroblasto. a citotoxicidade do extrato aquoso de semente de mostarda parece diminuir quando o extrato é tratado com calor a 120 °c por 15 minutos. o extrato aquoso de semente de mostarda tratado com calor quando combinado com mirosinase exógena não é citotóxico, mas pode induzir um aumento modesto no teor de ho-1 em fibroblastos cultivados e, assim, seria de esperar que fosse útil em uma composição tópica para tratar/ evitar coceira na pele, particularmente no couro cabeludo. essa invenção refere-se, assim, à provisão de uma composição tópica para tratar/evitar coceira na pele, particularmente no couro cabeludo.
BR112016025370A 2014-05-01 2015-04-21 composição tópica BR112016025370A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14166785 2014-05-01
PCT/EP2015/058574 WO2015165770A1 (en) 2014-05-01 2015-04-21 Topical composition

Publications (1)

Publication Number Publication Date
BR112016025370A2 true BR112016025370A2 (pt) 2017-08-15

Family

ID=50624499

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016025370A BR112016025370A2 (pt) 2014-05-01 2015-04-21 composição tópica

Country Status (5)

Country Link
US (1) US20170049676A1 (pt)
EP (1) EP3137170A1 (pt)
CN (1) CN106232102A (pt)
BR (1) BR112016025370A2 (pt)
WO (1) WO2015165770A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020161653A2 (en) * 2019-02-07 2020-08-13 Benny Antony Mustard extract enriched with sinigrin having increased bioactivity and bioavailability of allyl isothiocyanate
FR3104032B1 (fr) * 2019-12-06 2021-11-12 Lvmh Rech Composition cosmétique comprenant des extraits de kigélia et de capucine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5851754B2 (ja) * 1981-10-08 1983-11-18 四郎 酒井 高タンパク含有マスキング材料
US20030091518A1 (en) * 1999-12-20 2003-05-15 Gilles Pauly Cosmetic and/or pharmaceutical preparations
DE10308298A1 (de) * 2003-02-26 2004-09-09 Kullmer, Thomas, Priv. Doz. Dr. med. Verfahren zur Herstellung von Präparationen mit hochkonzentrierten Brassica-Inhaltsstoffen und deren Verwendung
EP1512406A1 (de) * 2003-09-03 2005-03-09 Cognis Iberia, S.L. Zubereitungen zur oralen Aufnahme
WO2006065736A2 (en) * 2004-12-14 2006-06-22 Johns Hopkins University Method of extraction of isothiocyanates into oil from glucosinolsate-containing plants
US20120052175A1 (en) * 2010-03-31 2012-03-01 Athula Ekanayake Process of Extracting Isothiocyanates

Also Published As

Publication number Publication date
WO2015165770A1 (en) 2015-11-05
US20170049676A1 (en) 2017-02-23
EP3137170A1 (en) 2017-03-08
CN106232102A (zh) 2016-12-14

Similar Documents

Publication Publication Date Title
CL2017000201A1 (es) Composiciones y métodos de uso para tratar trastornos metabólicos
CL2019000107A1 (es) Composiciones de arni contra el componente c5 del complemento y métodos para su uso.(divisional solicitud 201702014)
NI201700042A (es) Composiciones y métodos de uso para tratar trastornos metabólicos.
BR112015018726A2 (pt) composições compreendendo gougerotina e um fungicida
NI201600164A (es) Compuestos y composiciones como agonistas del receptor tipo toll 7
BR102016017090B8 (pt) Composição tópica de baixo ph e método para aumentar a aplicação tópica de um ingrediente ativo cosmeticamente aceitável
CR20170014A (es) Métodos para tratar el cáncer con inhibidores de tigit y agentes contra el cáncer
PH12019501323A1 (en) Compositions comprising sulfated polysaccharides
BR112017012327A2 (pt) benzamidas substituídas por 1,3-tiazol-2-il.
BR112017015310A8 (pt) uso de pgr4 como um agente anti-inflamatório
MX370624B (es) Composiciones que incluyen extractos de ampelopsis grossedentata y albizia julibrissin y métodos para uso.
BR112016023815A2 (pt) composições tópicas para o alívio da dor, produção e uso
CO2018005971A2 (es) Composición de regulador de crecimiento vegetal que tiene efecto sinérgico
BR112016000350A8 (pt) métodos de tratamento de lesões inflamatórias da rosácea e usos de uma composição farmacêutica
PH12016501251A1 (en) A topical composition
CL2019001014A1 (es) Métodos de tratamiento de afecciones relacionadas con la inflamación utilizando moduladores metabólicos y anti inflamatorios pluripotentes.
CR20150653A (es) Compuestos nuevos para el tratamiento del cáncer
MX2018007871A (es) Composiciones para el cuidado personal.
ZA202104166B (en) Sulcardine administration for treatment of acute atrial fibrillation
CL2019003484A1 (es) Neurotoxina botulínica para el tratamiento de trastornos asociados a hiperactividad de melanocitos y/o exceso de melanina.
BR112016029996A2 (pt) utilização cosmética, composição e método cosmético para tratar os odores corporais
BR112016025370A2 (pt) composição tópica
MX2018000538A (es) Composicion antimicrobiana.
PH12015502351A1 (en) Herbal compositions for treating pain and skin disorders
BR112015020182A2 (pt) uso cosmético de queuina ou de um precursor ou um derivado dessa como ingrediente ativo, uso de queuina ou um precursor ou um derivado dessa como ingrediente ativo, composição cosmética e processo de tratamento cosmético para prevenir e/ou tratar sinais de envelhecimento da pele e/ou anexos cutâneos

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]